Specificities of Human CD4+ T Cell Responses to an Inactivated Flavivirus Vaccine and Infection: Correlation with Structure and Epitope Prediction

ABSTRACT Tick-borne encephalitis (TBE) virus is endemic in large parts of Europe and Central and Eastern Asia and causes more than 10,000 annual cases of neurological disease in humans. It is closely related to the mosquito-borne yellow fever, dengue, Japanese encephalitis, and West Nile viruses, and vaccination with an inactivated whole-virus vaccine can effectively prevent clinical disease. Neutralizing antibodies are directed to the viral envelope protein (E) and an accepted correlate of immunity. However, data on the specificities of CD4+ T cells that recognize epitopes in the viral structural proteins and thus can provide direct help to the B cells producing E-specific antibodies are lacking. We therefore conducted a study on the CD4+ T cell response against the virion proteins in vaccinated people in comparison to TBE patients. The data obtained with overlapping peptides in interleukin-2 (IL-2) enzyme-linked immunosorbent spot (ELISpot) assays were analyzed in relation to the three-dimensional structures of the capsid (C) and E proteins as well as to epitope predictions based on major histocompatibility complex (MHC) class II peptide affinities. In the C protein, peptides corresponding to two out of four alpha helices dominated the response in both vaccinees and patients, whereas in the E protein concordance of immunodominance was restricted to peptides of a single domain (domain III). Epitope predictions were much better for C than for E and were especially erroneous for the transmembrane regions. Our data provide evidence for a strong impact of protein structural features that influence peptide processing, contributing to the discrepancies observed between experimentally determined and computer-predicted CD4+ T cell epitopes. IMPORTANCE Tick-borne encephalitis virus is endemic in large parts of Europe and Asia and causes more than 10,000 annual cases of neurological disease in humans. It is closely related to yellow fever, dengue, Japanese encephalitis, and West Nile viruses, and vaccination with an inactivated vaccine can effectively prevent disease. Both vaccination and natural infection induce the formation of antibodies to a viral surface protein that neutralize the infectivity of the virus and mediate protection. B lymphocytes synthesizing these antibodies require help from other lymphocytes (helper T cells) which recognize small peptides derived from proteins contained in the viral particle. Which of these peptides dominate immune responses to vaccination and infection, however, was unknown. In our study we demonstrate which parts of the proteins contribute most strongly to the helper T cell response, highlight specific weaknesses of currently available approaches for their prediction, and demonstrate similarities and differences between vaccination and infection.

[1]  L. Malherbe,et al.  Antigen‐driven T‐cell repertoire selection during adaptive immune responses , 2011, Immunology and cell biology.

[2]  D. Anthony,et al.  T-cell epitope mapping using the ELISPOT approach. , 2003, Methods.

[3]  L. Eisenlohr,et al.  Beyond the classical: Influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways , 2011, Immunologic research.

[4]  Darren R. Flower,et al.  MHC Class II Binding Prediction—A Little Help from a Friend , 2010, Journal of biomedicine & biotechnology.

[5]  J. Allison,et al.  Strength of TCR–Peptide/MHC Interactions and In Vivo T Cell Responses , 2011, The Journal of Immunology.

[6]  J. McLinden,et al.  Viruses within the Flaviviridae Decrease CD4 Expression and Inhibit HIV Replication in Human CD4+ Cells1 , 2009, The Journal of Immunology.

[7]  P. Scherle,et al.  Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin , 1986, The Journal of experimental medicine.

[8]  B. Lambrecht,et al.  IL-2 Producing Memory CD4+ T Lymphocytes Are Closely Associated with the Generation of IgG-Secreting Plasma Cells1 , 2008, The Journal of Immunology.

[9]  Tim D. Jones,et al.  Prediction of Immunogenicity of Therapeutic Proteins , 2010, BioDrugs.

[10]  K. Stiasny,et al.  Molecular mechanisms of flavivirus membrane fusion , 2011, Amino Acids.

[11]  K. Stiasny,et al.  Quantitative determination of IgM antibodies reduces the pitfalls in the serodiagnosis of tick-borne encephalitis. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[12]  T. Ishikawa,et al.  Flaviviruses , 2005, Perspectives in Medical Virology.

[13]  G. Chang,et al.  A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines. , 2012, Virology.

[14]  S. Kashiwagi,et al.  Identification of an epitope for T-cells correlated with antibody response to hepatitis B surface antigen in vaccinated humans. , 1996, Human immunology.

[15]  V. Bruss Envelopment of the hepatitis B virus nucleocapsid. , 2004, Virus research.

[16]  P. Doherty,et al.  Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Francisco A. Chaves,et al.  Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design , 2007, Expert review of vaccines.

[18]  Francisco A. Chaves,et al.  Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins. , 2010, Viral immunology.

[19]  G. B. Thornton,et al.  Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site , 1987, Nature.

[20]  Qinfen Zhang,et al.  CryoEM structure of the mature dengue virus at 3.5-Å resolution , 2012, Nature Structural &Molecular Biology.

[21]  Marian C. Horzinek,et al.  Flaviviridae. , 2020, Intervirology.

[22]  L. Stern,et al.  Human CD4+ T Cell Epitopes from Vaccinia Virus Induced by Vaccination or Infection , 2007, PLoS pathogens.

[23]  A. McMichael,et al.  Revealing the role of CD4+ T cells in viral immunity , 2012, The Journal of experimental medicine.

[24]  B. Maillère,et al.  In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R. , 2009, Molecular immunology.

[25]  P. Scherle,et al.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[26]  T. Pierson,et al.  Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection , 2008, Expert Reviews in Molecular Medicine.

[27]  John Sidney,et al.  A Systematic Assessment of MHC Class II Peptide Binding Predictions and Evaluation of a Consensus Approach , 2008, PLoS Comput. Biol..

[28]  F. Heinz,et al.  Homogeneity of the structural glycoprotein from European isolates of tick-borne encephalitis virus: comparison with other flaviviruses. , 1981, The Journal of general virology.

[29]  Morten Nielsen,et al.  Peptide binding predictions for HLA DR, DP and DQ molecules , 2010, BMC Bioinformatics.

[30]  D. Strick,et al.  Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.

[31]  A. Rudensky,et al.  The lysosomal cysteine proteases in MHC class II antigen presentation , 2005, Immunological reviews.

[32]  J. Neefjes,et al.  Towards a systems understanding of MHC class I and MHC class II antigen presentation , 2011, Nature Reviews Immunology.

[33]  R. Olveda,et al.  Human CD4+ memory T-lymphocyte responses to SARS coronavirus infection , 2007, Virology.

[34]  N. K. Steede,et al.  Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes. , 2007, Molecular immunology.

[35]  W. Mayr,et al.  An HLA-DR11 variant (HLA-DRB1*1115) segregating in a family of Turkish origin. , 1995, Tissue antigens.

[36]  Wei Zhang,et al.  Structure of Dengue Virus Implications for Flavivirus Organization, Maturation, and Fusion , 2002, Cell.

[37]  C. Mandl,et al.  Isolation of Capsid Protein Dimers from the Tick-Borne Encephalitis Flavivirus and In Vitro Assembly of Capsid-Like Particles , 2004, Journal of Virology.

[38]  K. Stiasny,et al.  Characteristics of antibody responses in tick-borne encephalitis vaccination breakthroughs. , 2009, Vaccine.

[39]  P. Marrack,et al.  Host DNA released in response to aluminum adjuvant enhances MHC class II-mediated antigen presentation and prolongs CD4 T-cell interactions with dendritic cells , 2013, Proceedings of the National Academy of Sciences.

[40]  K. Stiasny,et al.  Mechanistic insights into the impairment of memory B cells and antibody production in the elderly , 2013, AGE.

[41]  S. Harrison,et al.  The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution , 1995, Nature.

[42]  Scott A. Brown,et al.  Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity 1 , 2003, The Journal of Immunology.

[43]  K. Stiasny,et al.  Structure of a flavivirus envelope glycoprotein in its low‐pH‐induced membrane fusion conformation , 2004, The EMBO journal.

[44]  K. Stiasny,et al.  Dissection of Antibody Specificities Induced by Yellow Fever Vaccination , 2013, PLoS pathogens.

[45]  Hidde L. Ploegh,et al.  The known unknowns of antigen processing and presentation , 2008, Nature Reviews Immunology.

[46]  K. Welsh,et al.  Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection , 1995, Journal of virology.

[47]  Bernhard Knapp,et al.  PeptX: Using Genetic Algorithms to optimize peptides for MHC binding , 2011, BMC Bioinformatics.

[48]  P. Klenerman,et al.  Longitudinal mapping of protective CD4+ T cell responses against HCV: analysis of fluctuating dominant and subdominant HLA‐DR11 restricted epitopes , 2004, Journal of viral hepatitis.

[49]  K. Stiasny,et al.  Aluminum Hydroxide Influences Not Only the Extent but Also the Fine Specificity and Functional Activity of Antibody Responses to Tick-Borne Encephalitis Virus in Mice , 2013, Journal of Virology.

[50]  E. James,et al.  Yellow Fever Vaccination Elicits Broad Functional CD4+ T Cell Responses That Recognize Structural and Nonstructural Proteins , 2013, Journal of Virology.

[51]  J. Treanor,et al.  Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. , 2009, Vaccine.

[52]  R. -. Streeck,et al.  Novel transmembrane topology of the hepatitis B virus envelope proteins. , 1995, The EMBO journal.

[53]  A. Lanzavecchia,et al.  Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants , 1995, The Journal of experimental medicine.

[54]  L. Malherbe,et al.  Regulation of CD4 T‐cell receptor diversity by vaccine adjuvants , 2010, Immunology.

[55]  U. K. Laemmli,et al.  Maturation of the head of bacteriophage T4. II. Head-related, aberrant tau-particles. , 1973, Journal of molecular biology.

[56]  U. K. Laemmli,et al.  Maturation of the head of bacteriophage T4. I. DNA packaging events. , 1973, Journal of molecular biology.

[57]  A. Nesburn,et al.  Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity , 2003, Journal of Virology.

[58]  Kenneth G. C. Smith,et al.  Differential Targeting of Viral Components by CD4+ versus CD8+ T Lymphocytes in Dengue Virus Infection , 2012, Journal of Virology.

[59]  T. Strutt,et al.  Expanding roles for CD4+ T cells in immunity to viruses , 2012, Nature Reviews Immunology.

[60]  M. Feldmann,et al.  An influenza virus matrix protein‐specific human T cell line with helper activity for in vitro anti‐hemagglutinin antibody production , 1982, European journal of immunology.

[61]  John Sidney,et al.  Immunomic Analysis of the Repertoire of T-Cell Specificities for Influenza A Virus in Humans , 2008, Journal of Virology.

[62]  Francisco A. Chaves,et al.  Direct Ex Vivo Analyses of HLA-DR1 Transgenic Mice Reveal an Exceptionally Broad Pattern of Immunodominance in the Primary HLA-DR1-Restricted CD4 T-Cell Response to Influenza Virus Hemagglutinin , 2007, Journal of Virology.

[63]  C. Coban,et al.  DNA released from dying host cells mediates aluminum adjuvant activity , 2011, Nature Medicine.

[64]  S. Roh,et al.  Response of primed human PBMC to synthetic peptides derived from hepatitis B virus envelope proteins: a search for promiscuous epitopes. , 2003, FEMS immunology and medical microbiology.

[65]  D. Fremont,et al.  Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. , 2008, Cell host & microbe.

[66]  W. Schaffner,et al.  A rapid, sensitive, and specific method for the determination of protein in dilute solution. , 1973, Analytical biochemistry.

[67]  William W Kwok,et al.  CD4+ T cells recognize unique and conserved 2009 H1N1 influenza hemagglutinin epitopes after natural infection and vaccination. , 2013, International immunology.

[68]  E. Mariani,et al.  Epitope specificity of Th0/Th2 CD4+ T-lymphocyte clones induced by vaccination with rHBsAg vaccine. , 1997, Gastroenterology.

[69]  A. Pajot,et al.  Identification of novel HLA-DR1-restricted epitopes from the hepatitis B virus envelope protein in mice expressing HLA-DR1 and vaccinated human subjects. , 2006, Microbes and infection.

[70]  R. Kennedy,et al.  The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins , 2010, Virology.

[71]  G. Leroux-Roels,et al.  Characterization of the T cell recognition of hepatitis B surface antigen (HBsAg) by good and poor responders to hepatitis B vaccines , 2000, Clinical and experimental immunology.

[72]  Bong-Suk Kim,et al.  Structure of West Nile Virus , 2003, Science.

[73]  C. Watts,et al.  Antibody modulation of antigen presentation: positive and negative effects on presentation of the tetanus toxin antigen via the murine B cell isoform of FcγRII , 2002, European journal of immunology.

[74]  Ravi V. Kolla,et al.  Human CD8+ and CD4+ T Cell Memory to Lymphocytic Choriomeningitis Virus Infection , 2011, Journal of Virology.

[75]  P. Nuttall,et al.  Importance of localized skin infection in tick-borne encephalitis virus transmission. , 1996, Virology.

[76]  K. Stiasny,et al.  Flaviviruses and their antigenic structure. , 2012, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[77]  L. BenMohamed,et al.  Asymptomatic Human CD4+ Cytotoxic T-Cell Epitopes Identified from Herpes Simplex Virus Glycoprotein B , 2008, Journal of Virology.

[78]  James Robinson,et al.  The IMGT/HLA database , 2008, Nucleic Acids Res..

[79]  S. Landry Three-Dimensional Structure Determines the Pattern of CD4+ T-Cell Epitope Dominance in Influenza Virus Hemagglutinin , 2007, Journal of Virology.

[80]  J. Lamb,et al.  Human CD4+ T-cell recognition of influenza A virus hemagglutinin after subunit vaccination , 1996, Journal of virology.

[81]  W. Hennink,et al.  Identification of Formaldehyde-induced Modifications in Proteins , 2004, Journal of Biological Chemistry.

[82]  F. Liew,et al.  T cells primed by influenza virion internal components can cooperate in the antibody response to haemagglutinin , 1979, Nature.